Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Rang in Aktien #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Aktienkurs
$0.069
Zuletzt synchronisiert: 2024-07-22
Marktkapitalisierung
$2.06M
Veränderung (1 Tag)
-1.43%
Veränderung (1 Jahr)
0.00%
Land
US
Handel DermTech, Inc. (DMTK)

Kategorie

Anzahl der ausstehenden Aktien von DermTech, Inc. (DMTK)
Anzahl der ausstehenden Aktien zum March 2024: 34.71M
Laut den neuesten Finanzberichten und dem Aktienkurs von DermTech, Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 34.71M. Am Ende von December 2022 hatte das Unternehmen 30.04M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von DermTech, Inc. (DMTK) von 2012 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 34.71M 6.33%
2023 32.64M 8.66%
2022 30.04M 4.00%
2021 28.89M 70.12%
2020 16.98M 142.38%
2019 7.01M 196.70%
2018 2.36M 29.52%
2017 1.82M -61.36%
2013 4.72M 37.11%
2012 3.44M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
371.00M 968.98%
US
705.30M 1,932.21%
US
- -
CN
143.28M 312.84%
US
80.10M 130.78%
US